Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells

Details for Australian Patent Application No. 2010319680 (hide)

Owner Q Therapeutics, Inc.

Inventors Sandrock, Robert; Campanelli, James T.; Eppstein, Deborah A.

Agent FB Rice

Pub. Number AU-A-2010319680

PCT Pub. Number WO2011/059952

Priority 61/260,441 12.11.09 US; 61/326,799 22.04.10 US

Filing date 9 November 2010

Wipo publication date 19 May 2011

International Classifications

C12N 5/071 Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

C12N 13/00 Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/059952 Priority application(s): WO2011/059952

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010319681-Drug products, dry powder inhalers and polyflux collider arrangements

2010319678-Actinobacillus suis antigens